Gary N. Gross

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial

Mani S. Kavuru, Julian Melamed, Gary N. Gross et al. · Journal of Allergy and Clinical Immunology · 2000 · 240 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial

John A. Smith, Michael M. Kitt, Alyn H. Morice et al. · The Lancet Respiratory Medicine · 2020 · 224 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Omalizumab improves asthma-related quality of life in patients with severe allergic asthma

Albert F. Finn, Gary N. Gross, Julius van Bavel et al. · Journal of Allergy and Clinical Immunology · 2003 · 173 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +12

Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: A 90-day multi-center study

Donald P. Tashkin, Ashutosh Kumar, Eugene R. Bleecker et al. · The American Journal of Medicine · 1986 · 159 citations

Medicine, Pharmacology, Pharmacotherapy +13

Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus

Ulrich R. Hengge, W. Kŕause, Heidelore Hofmann et al. · British Journal of Dermatology · 2006 · 141 citations

Medicine, Dermatology, Autoimmunity +11